Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
Talquetamab for people living with relapsed/ refractory multiple myeloma: plain language summary of the MonumenTAL-1 study.
Journal: Future oncology (London, England)
Published: August 30, 2026
Treatment of Multiple Myeloma: ASCO Living Guideline, Version 2026.1.1.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 20, 2026
Treatment of Multiple Myeloma: ASCO-Ontario Health (Cancer Care Ontario) Living Guideline.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: January 06, 2026
Comparative Effectiveness of Ciltacabtagene Autoleucel in CARTITUDE-4 Versus Real-World Physician's Choice of Therapy from the Flatiron Registry in Lenalidomide-Refractory Multiple Myeloma.
Journal: Advances in therapy
Published: May 08, 2025
Comparative Efficacy of Ciltacabtagene Autoleucel Versus Standard-of-Care Treatments for Patients with Previously Treated Relapsed or Refractory Multiple Myeloma: A Matching-Adjusted Indirect Comparison.
Journal: Advances in therapy
Published: January 29, 2025
Characterization and Management of Cytokine Release Syndrome From the MonumenTAL-1 Study of Talquetamab in Patients With Relapsed/Refractory Multiple Myeloma.
Journal: Cancer medicine
Published: January 22, 2025
Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1-2 study.
Journal: The Lancet. Haematology
Published: August 29, 2024
Personalized Treatment of Multiple Myeloma in Frail Patients.
Journal: Current oncology reports
Published: May 07, 2024
Clinical Management of Patients With Relapsed/Refractory Multiple Myeloma Treated With Talquetamab.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 11, 2024
Selinexor-Based Triplet Regimens in Patients With Multiple Myeloma Previously Treated With Anti-CD38 Monoclonal Antibodies.
Journal: Clinical lymphoma, myeloma & leukemia
Published: April 04, 2023
Last Updated: 09/26/2026